19 December 2022 - The European Commission, the Heads of Medicines Agencies and the EMA have published recommendations that aim to facilitate the conduct of decentralised clinical trials while safeguarding the rights and well-being of participants as well as the robustness and reliability of the data collected.
This is an outcome of their joint initiative to Accelerate Clinical Trials in the European Union.